Author(s):
|
Faraco, J.; Lin, L.; Kornum, B.R.; Kenny, E.E.; Trynka, G.; Einen, M.; Rico, T.J.; Lichtner, P.; Dauvilliers, Y.; Arnulf, I.; Lecendreux, M.; Javidi, S.; Geisler, P.; Mayer, G.; Pizza, F.; Poli, F.; Plazzi, G.;
Overeem, S.
; Lammers, G.J.; Kemlink, D.; Sonka, K.; Nevsimalova, S.; Rouleau, G.; Desautels, A.; Montplaisir, J.; Frauscher, B.; Ehrmann, L.; Hogl, B.; Jennum, P.; Bourgin, P.; Peraita-Adrados, R.; Iranzo, A.; Bassetti, C.; Chen, W.M.; Concannon, P.; Thompson, S.D.; Damotte, V.; Fontaine, B.; Breban, M.; Gieger, C.; Klopp, N.; Deloukas, P.; Wijmenga, C.; Hallmayer, J.; Onengut-Gumuscu, S.; Rich, S.S.; Winkelmann, J.; Mignot, E.
|
Subject:
|
DCN MP - Plasticity and memory |
Abstract:
|
Recent advances in the identification of susceptibility genes and environmental exposures provide broad support for a post-infectious autoimmune basis for narcolepsy/hypocretin (orexin) deficiency. We genotyped loci associated with other autoimmune and inflammatory diseases in 1,886 individuals with hypocretin-deficient narcolepsy and 10,421 controls, all of European ancestry, using a custom genotyping array (ImmunoChip). Three loci located outside the Human Leukocyte Antigen (HLA) region on chromosome 6 were significantly associated with disease risk. In addition to a strong signal in the T cell receptor alpha (TRA@), variants in two additional narcolepsy loci, Cathepsin H () and Tumor necrosis factor (ligand) superfamily member 4 (, also called ), attained genome-wide significance. These findings underline the importance of antigen presentation by HLA Class II to T cells in the pathophysiology of this autoimmune disease.
|